What is Ligand Pharmaceuticals's components?

Ligand Pharmaceuticals (LGND) reported components of 194 in Q1 2026.

How has Ligand Pharmaceuticals's components changed year-over-year?

Ligand Pharmaceuticals's components increased by 487.9% year-over-year, from 33 to 194.

What does components mean?

This represents a granular breakdown or specific sub-category of a larger financial statement line item. It is used to provide transparency into the composition of complex balance sheet or income statement accounts. Investors analyze these components to understand the underlying drivers of specific financial performance metrics.

Ligand Pharmaceuticals LGND Components

Components at other companies

Banner CorporationBANR

191-4.0%

BioCryst PharmaceuticalsBCRX

8+300%

Assured GuarantyAGO

1.4K+2.9%

Dorman ProductsDORM

$247.32M+1.6%

First BanCorpFBP

2.5%—

Independent Bank CorpINDB

281+79.0%

Other financials

Income statement

See full

Revenue$51.7M+14.1%

Operating income$17.4M+148%

Net income-$13.3M+68.6%

EPS (diluted)-$0.67+69.7%

Balance sheet

See full

Cash & equivalents$115.1M+140%

Total debt$5.1M+14.2%

Total equity$997.3M+25.4%

Total assets$1.5B+69.2%

Cash flow

See full

Operating cash flow$48.7M+291%

CapEx$228.0K+6.5%

Free cash flow$48.5M+289%

Valuation

See full

Market cap$5.6B+96.7%

Profitability

See full

Gross margin91.9%—

Operating margin34.5%+23.0pp

Net margin55.9%+35.7pp

FCF margin44.8%+16.8pp

Returns & leverage

See full

Return on equity17.1%+11.5pp

Debt / equity0×0.0×

Current ratio21.3×+16.0×

Where this comes from

Reported directly by Ligand Pharmaceuticals in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleUnrealizedLossPositionNumberOfPositions.

The official record: Ligand Pharmaceuticals’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ligand Pharmaceuticals's components.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Ligand Pharmaceuticals's components?: Ligand Pharmaceuticals (LGND) reported components of 194 in Q1 2026.
How has Ligand Pharmaceuticals's components changed year-over-year?: Ligand Pharmaceuticals's components increased by 487.9% year-over-year, from 33 to 194.
What does components mean?: This represents a granular breakdown or specific sub-category of a larger financial statement line item. It is used to provide transparency into the composition of complex balance sheet or income statement accounts. Investors analyze these components to understand the underlying drivers of specific financial performance metrics.